Cimetidine Tablet (Cimetidine)
Cimetidine
Prescription medication
IYON Pharmaceutical Co., Ltd.
MFDS item code 201403623 · Approved 2014.08.05
This product's status changed to Approval withdrawn on 2023.06.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of ulcers and reflux esophagitis, Zollinger-Ellison syndrome, and improvement of gastric lesions
This drug is used for conditions such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also helps improve gastric mucosal lesions, such as erosions, bleeding, redness, and edema that occur during acute exacerbations of acute gastritis and chronic gastritis. This drug is effective in protecting the gastric mucosa and alleviating inflammation, thereby improving gastrointestinal symptoms.
Adults: Administer cimetidine 400 mg orally twice daily (morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased according to the patient; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this drug twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more, but use caution. In patients with severe renal impairment, the drug may accumulate in the body, so reduce the frequency of administration to the minimum according to the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis, administer the drug again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Administer orally in divided doses at 20 〜 40 mg per kg of body weight per day.
This drug should be cut very carefully when using a glass ampoule injection, as glass fragments may mix in. Special caution is needed when used for children or the elderly. Patients with hypersensitivity to this drug or allergic to its constituents, as well as patients taking Dofetilide, should not be administered this drug. The risk of cardiac arrhythmia may increase when used in conjunction with Dofetilide. Patients with reduced kidney or liver function, those with a history of drug allergies, the elderly, children under 19 years of age, and patients undergoing dialysis should use this drug with caution. Additionally, this drug can mask symptoms of gastric cancer, so it should be used only after ensuring the malignancy status. This drug can cause various side effects, such as reduced blood cell counts, liver dysfunction, kidney dysfunction, hypersensitivity reactions, endocrine disorders, gastrointestinal symptoms, neurological disorders, cardiovascular disorders, and skin reactions. If any abnormal symptoms occur, immediate discontinuation of the drug and medical attention is required. The minimum effective dose should be used while monitoring the treatment effect, and if ineffective, other treatment methods should be considered. Extra caution is required for the elderly or those with a history of peptic ulcers, and regular blood tests and liver and kidney function tests should be conducted. This drug may interact with various other medications, so careful dose adjustment and caution are needed when used in combination with anticoagulants, anxiolytics, cardiac medications, antidepressants, diabetes medications, etc. Pregnant women or women who may become pregnant should only use this drug when the therapeutic benefits outweigh the risks, and breastfeeding women should discontinue breastfeeding when this drug is administered. Safety in children has not been sufficiently confirmed, so it should be used cautiously only when necessary. The elderly should use this drug with caution, as the drug may remain in their body longer due to reduced kidney function, requiring dose reduction or increased dosing intervals. In case of overdose, serious symptoms such as respiratory depression may occur, necessitating immediate emergency treatment. When used as an injection, rapid intravenous administration may cause arrhythmias or blood pressure drops, so it should be administered slowly. This drug should be kept out of the reach of children, and care should be taken not to transfer it to another container, as this may adversely affect its quality.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light, so it should be stored in a container that blocks light. Furthermore, it is important to maintain a storage temperature of 1 to 30 degrees Celsius. This ensures that the drug's efficacy is well maintained and can be used safely.
Pale green pentagonal tablet
1000 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cimetidine
Prescription medication
IYON Pharmaceutical Co., Ltd.
Cimetidine 200mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cimetidine 200mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Cimetidine 100mg
Prescription medication
(Company) Yuhan Corporation

Cimetidine 200mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Cimetidine 200mg
Tablet · Prescription medication
Bukwang Pharmaceutical Co., Ltd.
Cimetidine 200mg
Tablet · Prescription medication
Bionex Co., Ltd.

Cimetidine 300mg
Tablet · Prescription medication
Bukwang Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.